Breaking News, Collaborations & Alliances

Microsize Signs Long-Term Supply Agreement with Cerus Corporation

Will provide high-throughput particle sizing services for the functional powders used in the INTERCEPT Blood System for Plasma.

Author Image

By: Charlie Sternberg

Associate Editor

Microsize has signed a long-term supply agreement with Cerus Corporation to provide high-throughput particle sizing services for the functional powders used in the INTERCEPT Blood System for Plasma, a pathogen inactivation technology used by blood centers around the world to help safeguard the blood supply.   The new supply agreement includes a joint CAPEX investment to build additional dedicated manufacturing suite capacity in 2023 and to qualify a higher-throughput processing train. These in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters